Latest News
Netflix Stock Slips 7.8% Ad Forecast Cut Deepens Investor Concerns
Netflix (NFLX) slid to $74.23 as ad revenue forecasts were cut by 7.8%, overshadowing a strong buyback. Q2 revenue missed estimates, and the stock remains 41% below its 52-week high.
Teradyne Soars 6% on AI Test Demand, Q3 Guidance Beats Estimates
Teradyne (TER) surged 6% after AI-related revenue topped 60% of Q2 sales and Q3 guidance beat estimates by 21%, underscoring strong chip-testing demand.
Keel Infrastructure Gains 9.6% on Stronger Liquidity Despite Revenue Slump
Keel Infrastructure (KEEL) shares jumped 9.6% after reporting $819 million in liquidity, offsetting a 50% revenue decline. The company is in talks for AI data-center leases.
Merck Stock Rises on MMR Split Order, but Revenue Gains Remain Distant
Merck (MRK) shares rose 1.89% after a presidential order to develop separate measles, mumps, and rubella vaccines, but analysts note the process could take over a decade and won't boost near-term revenue.
Brinker Soars 6% as Chili's Growth Streak Boosts FY2027 Outlook
Brinker International (EAT) rallied 6% as Chili's comparable sales climbed 5.6%, marking a fifth consecutive year of growth, and FY2027 EPS guidance topped expectations.
Astronics Soars 15% as Backlog Hits Record 76% of Revenue Target
Astronics (ATRO) jumped 15% after reporting record backlog of $780.6M, covering 76% of its raised revenue guidance. Q2 sales rose 27% and adjusted EBITDA more than doubled.
Ondas Faces Steep H2 Revenue Hurdle Ahead of Q2 Earnings
Ondas Holdings (ONDS) shares were flat ahead of Q2 earnings, with a $406 million H2 revenue goal requiring near-triple quarterly growth. Analysts remain bullish despite high expectations.
Archer Aviation Shares Slide 8% on Boeing Deal Dilution Concerns
Archer Aviation shares fell 8.2% as investors digested the Boeing acquisition's dilution impact, despite the deal bringing over $200 million in annual revenue.
Humana Gains as COLA Estimate Overlooks Rising Medical Costs
Humana stock gained 2.6% as a preliminary 3.1% COLA estimate for 2027 overshadowed rising medical costs, which continue to pressure the insurer's margins.
SpaceX Shares Surge 4% as AI Valuation Debate Heats Up
SpaceX shares rose 4.2% to $138.93, adding $74B in market cap. Q2 revenue nearly doubled, but AI losses and upcoming share unlock present risks.
Bunge Stock Steady as Wheat Jumps; Oilseeds Drive 88% of Profit
Bunge (BG) shares stayed flat as wheat futures climbed 3% after a Ukrainian attack halted two Russian grain terminals. Oilseed processing drove 88% of Q2 segment profit.